[Translation] Phase III, open-label, randomized controlled study of eutenedron combined with AC versus docetaxel combined with AC in neoadjuvant chemotherapy for HER2-negative early high-risk or locally advanced breast cancer
评估优替德隆联合多柔比星+环磷酰胺(AC)化疗方案对比多西他赛联合多柔比星+环磷酰胺(AC)方案用于HER2阴性早期高危或局部晚期乳腺癌新辅助化疗的疗效和安全性
[Translation] To evaluate the chemotherapy regimen of eutedron combined with doxorubicin + cyclophosphamide (AC) versus docetaxel combined with doxorubicin + cyclophosphamide (AC) in neoadjuvant chemotherapy for HER2-negative early high-risk or locally advanced breast cancer Efficacy and safety of chemotherapy